Matvey Yagudayev, DPM
Foot & Ankle Surgery · Brooklyn, NYNPI 1588076806
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Paragon 28, Inc. at 26.8% of the total. Reporting peaked in 2021 at $1,853 and has fallen 65.9% since, to $633 in 2025.
Across 50 payments — averaging $107.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$1K
- Gotham Surgical Solutions & Devices, Inc.$1K
- Smith+Nephew$633
- Linvatec Corporation$460
- Treace Medical Concepts, Inc.$345
- Orthofix Medical, Inc.$293
- plus $1K from 13 others
What the payments were for
- Travel & lodging$1,55229%
- Food & beverage$2,63049%
- Education$1,20022%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 3 | $1,441 |
| Gotham Surgical Solutions & Devices, Inc. | 1 | $1,200 |
| Smith+Nephew | 12 | $633 |
| Linvatec Corporation | 2 | $460 |
| Treace Medical Concepts, Inc. | 3 | $345 |
| Orthofix Medical, Inc. | 7 | $293 |
| Zimmer Biomet | 3 | $188 |
| Stryker | 1 | $172 |
| Ossio Inc | 1 | $167 |
| Acera Surgical, Inc. | 1 | $149 |
| Amgen | 4 | $75 |
| Organogenesis Inc. | 3 | $70 |
| Paratek Pharmaceuticals, Inc. | 2 | $43 |
| Nevro Corp. | 1 | $34 |
| Merck | 2 | $30 |
| Alfasigma USA, Inc. | 1 | $27 |
| Royal Biologics, Inc. | 1 | $25 |
| DJO, LLC | 1 | $15 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$980
- PODIATRY COURSE$461
- NeoSpan$266
- Lapiplasty System$233
- Stravix$209
- Grafix PL PRIME$209
- BioBrace 23mm$194
- PROSTEP MICA$172
- GRAVITY$172
- BIOskin$172
- VARIAX$172
- ORTHOLOC 3DI$172
- Restrata Wound Matrix$149
- Stratum Foot Plating System$145
- Regeneten$135
- Physio-Stim$129
- GRAFIX PL$105
How this compares
$5,382 in reported general payments places this provider in the 70th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 17 | $18,583 |
| Oxiconazole Nitrate | 14 | $14,686 |
| Tavaborole | 13 | $6,724 |
| Ketoconazole | 15 | $955 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 30 | $715 |
| Ammonium Lactate | 22 | $385 |
| Meloxicam | 18 | $54 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Brooklyn
- Yury RotshteynBrooklyn$43K
- Mario VoloshinBrooklyn$33K
- Bryan MakowerBrooklyn$28K
- Amit GandhiBrooklyn$21K
- Edward AzarBrooklyn$18K
- James McWilliamHarrison$4.7M
- Jonathan DelandNew York$4M
- George Vitole Roy$2.5M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.